O-Methylhydroxylamine hydrochloride → N-(5-bromo-pyrazin-2-yl)-2-(3-chloro-4-methanesulfonyl-phenyl)-3-(4-methoxyimino-cyclohexyl)-propionamide
Reaction equation
Cl.[O:2]([NH2:4])[CH3:3].[Br:5][C:6]1[N:7]=[CH:8][C:9]([NH:12][C:13](=[O:34])[CH:14]([C:23]2[CH:28]=[CH:27][C:26]([S:29]([CH3:32])(=[O:31])=[O:30])=[C:25]([Cl:33])[CH:24]=2)[CH2:15][CH:16]2[CH2:21][CH2:20][C:19](=O)[CH2:18][CH2:17]2)=[N:10][CH:11]=1>CO.N1C=CC=CC=1>[Br:5][C:6]1[N:7]=[CH:8][C:9]([NH:12][C:13](=[O:34])[CH:14]([C:23]2[CH:28]=[CH:27][C:26]([S:29]([CH3:32])(=[O:30])=[O:31])=[C:25]([Cl:33])[CH:24]=2)[CH2:15][CH:16]2[CH2:21][CH2:20][C:19](=[N:4][O:2][CH3:3])[CH2:18][CH2:17]2)=[N:10][CH:11]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 25 °C
Procedure
A solution of methoxylamine hydrochloride (16 mg, 0.18 mmol) in methanol (0.5 mL) and pyridine (0.5 mL) was treated with N-(5-bromo-pyrazin-2-yl)-2-(3-chloro-4-methanesulfonyl-phenyl)-3-(4-oxo-cyclohexyl)-propionamide (prepared as in Example 59, 62 mg, 0.12 mmol). The reaction mixture was heated under reflux for 2 h, cooled to 25° C., and concentrated in vacuo to remove methanol. The resulting residue was suspended in ethyl acetate (10 mL), washed with water 1×5 mL), dried over magnesium sulfate, filtered, and concentrated in vacuo. Biotage chromatography (FLASH 12M, Silica, 7/3 hexanes/ethyl acetate eluted to 4/6 hexanes/ethyl acetate) afforded the N-(5-bromo-pyrazin-2-yl)-2-(3-chloro-4-methanesulfonyl-phenyl)-3-(4-methoxyimino-cyclohexyl)-propionamide (51 mg, 80%) as a white foam: EI-HRMS m/e calcd for C21H24BrClN4O4S (M+H)+ 543.0463. found 543.0464.
Workup
- temperatureThe reaction mixture was heated
- temperatureunder reflux for 2 h
- concentrationconcentrated in vacuo
- customto remove methanol
- washwashed with water 1×5 mL),
- dry with materialdried over magnesium sulfate
- filtrationfiltered
- concentrationconcentrated in vacuo
- washBiotage chromatography (FLASH 12M, Silica, 7/3 hexanes/ethyl acetate eluted to 4/6 hexanes/ethyl acetate)
Sources & evidence
- ORD record
- ord-3b7920bd5b8049d183fccc17107260f6
- Source dataset
- uspto-grants-2007_08
- Patent number
- US07259166B2
Reaction notes
Loading…